MBX Biosciences reported Q2 results highlighting progress on canvuparatide and MBX 4291 in the obesity pipeline with a robust cash balance....
Financial News Archive
SEC EDGAR · Federal Reserve · FDA · BLS · Updated every 60s
Insight Enterprises reported strong earnings growth driven by AI momentum. The company raised full-year guidance as cloud, infrastructure, and service...
Novavax reported $57M revenue and upwardly revised its 2026 revenue guidance driven by potential earnings from a Sanofi combination trial and existing...
Aurinia Pharmaceuticals reported strong Q2 earnings with 21% revenue growth and a 60% increase in net income. The company also provided updated 2026 g...
Prime Medicine secured global regulatory clearance for its Wilson disease program. The company also reported a favorable arbitration outcome for its A...
Globalstar reported $64.8 million in Q2 revenue driven by Commercial IoT growth. The company announced progress in its merger with Amazon, with the HS...
USA TODAY reported positive net income and free cash flow for Q2 2026 while reaffirming its full-year outlook. Total revenues declined 8.3% year-over-...
Hertz reported Q2 2026 revenue of $2.4 billion, up 10% year-over-year, demonstrating strong commercial execution. The strong performance was attribute...
Parker-Hannifin posted record sales and adjusted earnings for FY26, beating expectations. The company raised its adjusted segment operating margin tar...
Partner reported a $17.5M net loss for the third quarter of fiscal 2026, driven by warmer temperatures reducing demand, though volumes were supported ...
Viatris reported Q2 2026 Total Revenues of $3.8B and Adjusted EBITDA of $1.2B. The company raised full-year 2026 guidance and returned $550M to shareh...
Agenus reported Q2 2026 results and announced an accelerated Phase 3 trial for neoadjuvant colon cancer. The trial is fully funded via a July 2026 pri...
Institutional holdings report (13F-HR) filed by ABN AMRO Bank N.V.....
Cars.com reported Q2 2026 revenue of $179.9 million and a net increase of 103%, driven by sustainable profitability and 7% Marketplace revenue growth,...
Intellia released positive Phase 3 data for its HAE treatment lonvo-z, received FDA guidance, and ended the quarter with strong liquidity....
Lantheus reported Q2 2026 revenue of $388.2 million and EPS of $1.11, while announcing an all-cash agreement to merge with Curium for up to $8.0 billi...
Sabre Corp reported Q2 2026 revenue surpassing expectations while raising full-year adjusted EBITDA and free cash flow guidance, demonstrating strong ...
Deep Isolation reported $1.3 million in revenue with $3.0 million net loss, ahead of its first public trading experience where S-1 became effective an...
Biotech company PepGen reported financial results affirming long-term solvency. It announced positive breakthroughs in its DM1 trial, including a Data...
ATI Inc. reported Q2 2026 net income of $151 million, up 50% year-over-year, beating expectations. The company raised its adjusted EBITDA and EPS guid...